Cargando…

Glucagon-Like Peptide-1 Receptor Agonist Utilization in Type 2 Diabetes in Japan: A Retrospective Database Analysis (JDDM 57)

INTRODUCTION: There are limited real-world data on the prescribing of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for patients with type 2 diabetes mellitus (T2DM). METHODS: This was a retrospective analysis of the CoDiC® database of the Japan Diabetes Clinical Data Management Study Group...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishigaki, Yasushi, Strizek, Alena, Aranishi, Toshihiko, Arai, Nobuhiro, Imaoka, Takeshi, Cai, Zhihong, Maegawa, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843848/ https://www.ncbi.nlm.nih.gov/pubmed/33300091 http://dx.doi.org/10.1007/s13300-020-00977-w

Ejemplares similares

Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53)
por: Maegawa, Hiroshi, et al.
Publicado: (2020)

The renoprotective effect of once‐weekly GLP‐1 receptor agonist dulaglutide on progression of nephropathy in Japanese patients with type 2 diabetes and moderate to severe chronic kidney disease (JDDM67)
por: Tsuchida, Ken‐ichi, et al.
Publicado: (2022)

Clinical inertia in basal insulin-treated patients with type 2 diabetes – Results from a retrospective database study in Japan (JDDM 43)
por: Satoh, Jo, et al.
Publicado: (2018)

Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site
por: Aranishi, Toshihiko, et al.
Publicado: (2019)

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)
por: Shirabe, Shinichiro, et al.
Publicado: (2022)

Association between Obesity and Intake of Different Food Groups among Japanese with Type 2 Diabetes Mellitus—Japan Diabetes Clinical Data Management Study (JDDM68)
por: Hatta, Mariko, et al.
Publicado: (2022)

Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in Japan (JDDM32)
por: Oishi, Mariko, et al.
Publicado: (2013)

Current status of achieving blood pressure target and its clinical correlates in Japanese type 2 diabetes (JDDM45)
por: Yokoyama, Hiroki, et al.
Publicado: (2017)

Family Support for Medical Nutritional Therapy and Dietary Intake among Japanese with Type 2 Diabetes (JDDM 56)
por: Horikawa, Chika, et al.
Publicado: (2020)

Comparing Associations of Dietary Energy Density and Energy Intake, Macronutrients with Obesity in Patients with Type 2 Diabetes (JDDM 63)
por: Takeda, Yasunaga, et al.
Publicado: (2021)

Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46)
por: Yokoyama, Hiroki, et al.
Publicado: (2018)

Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66)
por: Yokoyama, Hiroki, et al.
Publicado: (2022)

Combination of disease duration‐to‐age at diagnosis and hemoglobin A1c‐to‐serum C‐peptide reactivity ratios predicts patient response to glucose‐lowering medication in type 2 diabetes: A retrospective cohort study across Japan (JDDM59)
por: Kanatsuka, Azuma, et al.
Publicado: (2021)

Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)
por: Yokoyama, Hiroki, et al.
Publicado: (2016)

Machine Learning Approach to Decision Making for Insulin Initiation in Japanese Patients With Type 2 Diabetes (JDDM 58): Model Development and Validation Study
por: Fujihara, Kazuya, et al.
Publicado: (2021)

Characteristics, Treatment Patterns, and Economic Outcomes of Patients Initiating Injectable Medications for Management of Type 2 Diabetes Mellitus in Japan: Results from a Retrospective Claims Database Analysis
por: Suzuki, Shuichi, et al.
Publicado: (2018)

Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61)
por: Yagi, Noriharu, et al.
Publicado: (2021)

Time and Costs of Insulin Treatment in the Care of Newly Registered Type 2 Diabetes Patients in Diabetes Clinics Across Japan (JDDM 22)
por: Oishi, Mariko, et al.
Publicado: (2011)

Patient and physician perspectives on alopecia areata: A real‐world assessment of severity and burden in Japan
por: Edson‐Heredia, Emily, et al.
Publicado: (2022)

Combined Effects of Energy Intake and Physical Activity on Obesity in Japanese Patients with Type 2 Diabetes (JDDM 50): A Cross-Sectional Study
por: Hatta, Mariko, et al.
Publicado: (2019)

Impact of Patient and Physician Disconnect on Satisfaction with Treatment for Atopic Dermatitis in Japan
por: Wang, Chaochen, et al.
Publicado: (2022)

Neural effects of gut‐ and brain‐derived glucagon‐like peptide‐1 and its receptor agonist
por: Katsurada, Kenichi, et al.
Publicado: (2016)

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38)
por: Kanatsuka, Azuma, et al.
Publicado: (2015)

The molecular pharmacology of glucagon agonists in diabetes and obesity
por: Novikoff, Aaron, et al.
Publicado: (2023)

Fasting Insulin Levels and Metabolic Risk Factors in Type 2 Diabetic Patients at the First Visit in Japan: A 10-year, nationwide, observational study (JDDM 28)
por: Matsuba, Ikuro, et al.
Publicado: (2012)

Evaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score‐matched cohort study across Japan (JDDM31)
por: Kanatsuka, Azuma, et al.
Publicado: (2014)

Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42)
por: Fujihara, Kazuya, et al.
Publicado: (2017)

Treatment costs and cost drivers among osteoporotic fracture patients in Japan: a retrospective database analysis
por: Taguchi, Yurie, et al.
Publicado: (2018)

Prevalence of alopecia areata in Japan: Estimates from a nationally representative sample
por: Aranishi, Toshihiko, et al.
Publicado: (2022)

Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
por: Sawada, Noritaka, et al.
Publicado: (2020)

Secular Trends in Dietary Intake over a 20-Year Period in People with Type 2 Diabetes in Japan: A Comparative Study of Two Nationwide Registries; Japan Diabetes Complications Study (JDCS) and Japan Diabetes Clinical Data Management Study (JDDM)
por: Takeuchi, Mizuki, et al.
Publicado: (2021)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

How glucagon-like peptide 1 receptor agonists work
por: Andreasen, Christine Rode, et al.
Publicado: (2021)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

Conformation Transition of Intracellular Part of Glucagon Receptor in Complex With Agonist Glucagon by Conventional and Accelerated Molecular Dynamics Simulations
por: Bai, Qifeng, et al.
Publicado: (2019)

Evaluating preferences for profiles of glucagon-like peptide-1 receptor agonists among injection-naive type 2 diabetes patients in Japan
por: Gelhorn, Heather L, et al.
Publicado: (2016)

A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes
por: Baxter, Mike, et al.
Publicado: (2020)

Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist S6 Stimulates Insulin Secretion From Rat Islets
por: Yang, Xiaohua, et al.
Publicado: (2021)

The Japan Neurosurgical Database: Statistics Update 2018 and 2019
por: IIHARA, Koji, et al.
Publicado: (2021)

Trends and determinant factors in the use of cardiac resynchronization therapy devices in Japan: Analysis of the Japan cardiac device treatment registry database
por: Yokoshiki, Hisashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_afvo59qclia6o160uegkhb86do